company background image
MDG1 logo

Medigene BRSE:MDG1 Stock Report

Last Price

CHF 16.00

Market Cap

CHF 29.2m

7D

0%

1Y

0%

Updated

06 Oct, 2024

Data

Company Financials +

My Notes

Capture your thoughts, links and company narrative

Medigene AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for Medigene
Historical stock prices
Current Share Price€16.00
52 Week High€0
52 Week Low€0
Beta0.84
1 Month Change0%
3 Month Change0%
1 Year Change0%
3 Year Change0%
5 Year Change0%
Change since IPO-41.22%

Recent News & Updates

Recent updates

Shareholder Returns

MDG1CH BiotechsCH Market
7D0%-4.1%-2.4%
1Y0%89.3%0.7%

Return vs Industry: MDG1 underperformed the Swiss Biotechs industry which returned 81.7% over the past year.

Return vs Market: MDG1 underperformed the Swiss Market which returned 9.8% over the past year.

Price Volatility

Is MDG1's price volatile compared to industry and market?
MDG1 volatility
MDG1 Average Weekly Movementn/a
Biotechs Industry Average Movement12.7%
Market Average Movement3.3%
10% most volatile stocks in CH Market7.4%
10% least volatile stocks in CH Market1.6%

Stable Share Price: MDG1's share price has been volatile over the past 3 months compared to the Swiss market.

Volatility Over Time: Insufficient data to determine MDG1's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
199487Selwyn Howww.medigene.com

Medigene AG, a biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer. The company’s end-to-end platform enables the development of T cell receptor engineered T cell (TCR-T) therapies for multiple tumor indications. Its pipeline includes MDG1015, a TCR-T therapy product to treat multiple solid tumor indications; MDG10xx to treat multiple solid tumor; and MDG1011, a TCR-T immunotherapy candidate, which is in clinical development to treat blood cancer.

Medigene AG Fundamentals Summary

How do Medigene's earnings and revenue compare to its market cap?
MDG1 fundamental statistics
Market capCHF 29.23m
Earnings (TTM)-CHF 15.01m
Revenue (TTM)CHF 7.02m

4.2x

P/S Ratio

-1.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MDG1 income statement (TTM)
Revenue€7.45m
Cost of Revenue€1.49m
Gross Profit€5.95m
Other Expenses€21.89m
Earnings-€15.93m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.08
Gross Margin79.94%
Net Profit Margin-213.98%
Debt/Equity Ratio0%

How did MDG1 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/06 09:33
End of Day Share Price 2024/07/09 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medigene AG is covered by 9 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xian DengBerenberg
Gary WaandersBryan Garnier & Co
Thibaud RutsaertGSN North America